Afoxolaner | Veterinary API for Oral Flea & Tick Control in Dogs 🐾
GMP-Certified Isoxazoline Class Parasiticide with Rapid Action
📌 Product Overview
Afoxolaner is a high-efficacy veterinary active pharmaceutical ingredient (API) belonging to the isoxazoline class, widely used in oral formulations for flea and tick control in dogs35. It targets the nervous system of parasites, ensuring rapid elimination and long-lasting protection35. Designed for veterinary drug manufacturers and pet healthcare product developers, it is essential for producing chewable tablets, topical solutions, and preventive care products35.
Key Applications:
Pet parasiticide formulations 🐕
Veterinary pharmaceutical production 🏭
Companion animal health products 💊
✅ Key Advantages
| 🔥 Feature | 📈 Specification/Effect |
|---|
| Purity ≥98% | HPLC/GC-MS validated, compliant with USP/EP standards35 |
| Rapid Efficacy | Kills fleas within 12 hours and ticks within 24 hours3 |
| Stable Formulation | Shelf life of 24 months under proper storage5 |
🌍 Applications
- Veterinary Drug Manufacturing
: Core API for oral flea/tick treatments35.
- Pet Care Products
: Integrated into chewables and topical solutions for dogs3.
- Veterinary Prescription Solutions
: Used in clinics for parasite management5.
📜 Quality Certifications
Produced under GMP and ISO 9001 guidelines.
Tested via HPLC, GC-MS, and microbiological assays.
Complies with ICH Q7 and VICH GL3 stability protocols.
📈 Market Trends
The global veterinary parasiticide market is projected to grow at 8.5% CAGR (2025-2030), driven by rising pet ownership and demand for safe, oral treatments35. Isoxazoline-class APIs like Afoxolaner dominate 65% of the market share, reflecting their proven efficacy and safety35.
China
